Download
Disease/health condition -
Cardiovascular health
Low-density lipoprotein (LDL)
Assay format
Optical methods on semi-automated or automated clinical chemistry analysers
Information History
First added in 2018
Changed in 2024
Purpose type
Prediction
Purpose
To assess risk of cardiovascular disease (CVD).
Specimen types
Serum, Plasma
WHO prequalified or recommended products
N/A
GMDN
N/A
N/A
N/A
The medical device term(s), code(s) and definition(s) in this section were retrieved from databases external to WHO. As there might be more than one name, definition and “Nomenclature Code” related to the specific medical device, please consult https://gmdnagency.org GMDN ®. © GMDN Agency 2005-2024EMDN
W01010221
LOW DENSITY LIPOPROTEIN CHOLESTEROL INCLUDING SD-LDL
The code(s) and term(s) in this section were observed and retrieved from public databases and have not been validated by health regulatory authorities. Please consult your regulatory agency and EMDN site: https://webgate.ec.europa.eu/dyna2/emdnWHO supporting publications
World Health Organization. (2018). Technical package for cardiovascular disease management in primary health care: evidence-based treatment protocols. World Health Organization. https://iris.who.int/handle/10665/260421 ; World Health Organization. (2018). Technical package for cardiovascular disease management in primary health care: access to essential medicines and technology. World Health Organization. https://iris.who.int/handle/10665/260420 ; World Health Organization. (2020). Hearts: technical package for cardiovascular disease management in primary health care: risk-based CVD management. World Health Organization. https://iris.who.int/handle/10665/333221; WHO list of priority medical devices for management of cardiovascular diseases and diabetes. (2021). https://iris.who.int/handle/10665/341967
Technical specifications
N/A
Related Medical Devices in MeDevIS
SAGE IVD recommended including this test in the EDL on the basis of the scientific validity of the analyte and the availability of WHO guidelines and technical reports, including recommendations for the use of this test. The selection of disease specific tests for the EDL also took into account relevant priority diseases for WHO such as NCDs including DM, CVD and cancer, HIV infection, malaria, NTDs, STIs, tuberculosis, viral hepatitis B and C, among others.
N/A
The inclusion of this test was based on WHO guidelines and/or technical documents that include recommendations for the use of this test.
N/A